FDA Issues a Recall of the Popular High Blood Pressure Drug Hydrochlorothiazide

Share

A pair of nationwide recalls, including tablets from different brand names and manufacturers, say that patients could face risky reactions or increase their cancer risk by taking unsafe or incorrect medication.

Accord Healthcare has recalled one lot of 12.5-milligram hydrochlorothiazide tablets because the 100-count bottle was discovered to contain 100 spironolactone tablets.

The recall was prompted after a pharmacy found a bottle that actually contained another medication called spironolactone.

The FDA says there could be a labeling mix-up, after finding a bottle filled with different medication inside.

The hydrochlorothiazide pills are light orange or peach in color, are round, and beget an "H" on one aspect and a "1" on the opposite.

If you have these drugs, the FDA asks you to please return to your pharmacy or healthcare provider for confirmation. After preliminary and interim investigations, the company believes no other lots of Hydrochlorothiazide Tablets are affected. Spironolactone tablets are used to treat congestive heart failure, cirrhosis of the liver, and other ailments.

Hydrochlorothiazide tablets are used in the treatment of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension.

Accord said those taking the drug run the risk of having too much potassium, which could be life-threatening for certain people.

Medication in that lot is now under a voluntary recall.

Accord hasn't received any reports of adverse health events related to this recall.

Accord is notifying wholesalers, distributors and retailers by letter.

Share